8
Contents Preface by David Wallach .......................... v Preface by Marc Feldmann ......................... ix Part I Roles of the TNF Family in Tissue Homeostasis and Normal Development 1 Workshop Summary: Roles of the TNF Family in Normal Development and Cancer ....................... 3 Nancy H. Ruddle 2 TNF Conference 2009: Beyond Bones – RANKL/RANK in the Immune System ........................ 5 Andreas Leibbrandt and Josef M. Penninger 3 The Edar Subfamily in Hair and Exocrine Gland Development .............................. 23 Marja L. Mikkola 4 High Endothelial Venule Reporter Mice to Probe Regulation of Lymph Node Vasculature ............... 35 Kevin L. Bentley, Sharon Stranford, Shan Liao, Rawad M. Mounzer, Frank H. Ruddle, and Nancy H. Ruddle 5 Eiger and Wengen: The Drosophila Orthologs of TNF/TNFR ............................. 45 Tatsushi Igaki, Hiroshi Kanda, Hideyuki Okano, Tian Xu, and Masayuki Miura Part II Novel Aspects of Signaling Activation by the TNF Family: Novel Aspects of the Functions of the TRAFs and cIAPs 6 Workshop Summary: Novel Aspects of the Functions of the TRAFs and cIAPs ........................... 53 John Silke and Domagoj Vucic xiii

Contents · Contents xv 16 Understanding Life and Death at CD95..... 151 Carina Pforr, Leo Neumann, Roland Eils, Peter H. Krammer, and Inna N. Lavrik 17 Unique Personalities Within

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

  • Contents

    Preface by David Wallach . . . . . . . . . . . . . . . . . . . . . . . . . . v

    Preface by Marc Feldmann . . . . . . . . . . . . . . . . . . . . . . . . . ix

    Part I Roles of the TNF Family in Tissue Homeostasisand Normal Development

    1 Workshop Summary: Roles of the TNF Family in NormalDevelopment and Cancer . . . . . . . . . . . . . . . . . . . . . . . 3Nancy H. Ruddle

    2 TNF Conference 2009: Beyond Bones – RANKL/RANKin the Immune System . . . . . . . . . . . . . . . . . . . . . . . . 5Andreas Leibbrandt and Josef M. Penninger

    3 The Edar Subfamily in Hair and Exocrine GlandDevelopment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23Marja L. Mikkola

    4 High Endothelial Venule Reporter Mice to ProbeRegulation of Lymph Node Vasculature . . . . . . . . . . . . . . . 35Kevin L. Bentley, Sharon Stranford, Shan Liao,Rawad M. Mounzer, Frank H. Ruddle, and Nancy H. Ruddle

    5 Eiger and Wengen: The Drosophila Orthologsof TNF/TNFR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45Tatsushi Igaki, Hiroshi Kanda, Hideyuki Okano, Tian Xu,and Masayuki Miura

    Part II Novel Aspects of Signaling Activation by the TNFFamily: Novel Aspects of the Functions of the TRAFsand cIAPs

    6 Workshop Summary: Novel Aspects of the Functions of theTRAFs and cIAPs . . . . . . . . . . . . . . . . . . . . . . . . . . . 53John Silke and Domagoj Vucic

    xiii

  • xiv Contents

    7 TRAF2 and Cellular IAPs: A Critical Link in TNFRFamily Signaling . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63Domagoj Vucic

    8 New Perspectives in TNF-R1-Induced NF-κB Signaling . . . . . . 79Ian E. Gentle and John Silke

    9 Structural Studies of NEMO and TRAF6: Implicationsin NF-κB Activation . . . . . . . . . . . . . . . . . . . . . . . . . . 89Hao Wu, Yu-Chih Lo, and Qian Yin

    Part III Novel Aspects of Signaling Activation by the TNF:Ubiquitin Modification of Signaling Proteins

    10 Modification by Single Ubiquitin MoietiesRather Than Polyubiquitination Is Sufficientfor Proteasomal Processing of the p105 NF-κB Precursor . . . . . 95Yelena Kravtsova-Ivantsiv, Shai Cohen,and Aaron Ciechanover

    11 Selective Binding of Linear Ubiquitin Chainsto NEMO in NF-kappaB Activation . . . . . . . . . . . . . . . . . 107Fumiyo Ikeda, Simin Rahighi, Soichi Wakatsuki,and Ivan Dikic

    12 The Linear Ubiquitin Chain Assembly Complex(LUBAC) Forms Part of the TNF-R1 Signalling Complexand Is Required for Effective TNF-Induced GeneInduction and Prevents TNF-Induced Apoptosis . . . . . . . . . . 115Christoph H. Emmerich, Anna C. Schmukle, Tobias L. Haas,Björn Gerlach, Stefanie M. Cordier, Eva Rieser,and Henning Walczak

    13 Temporal Control of TNFα Signaling by Miz1 . . . . . . . . . . . 127Anning Lin

    Part IV Novel aspects of Signaling Activation by the TNFFamily: TNF Signaling and Gene Regulatory Networks

    14 Large-Scale RNAi Screens to Dissect TNF and NF-κBSignaling Pathways . . . . . . . . . . . . . . . . . . . . . . . . . . 131Marie Metzig, Dorothee Nickles, and Michael Boutros

    15 Pathogenic Role of IL-6 Combined with TNF-α or IL-1in the Induction of Acute Phase Proteins SAA and CRPin Chronic Inflammatory Diseases . . . . . . . . . . . . . . . . . . 141Kazuyuki Yoshizaki

  • Contents xv

    16 Understanding Life and Death at CD95 . . . . . . . . . . . . . . . 151Carina Pforr, Leo Neumann, Roland Eils, Peter H. Krammer,and Inna N. Lavrik

    17 Unique Personalities Within the NF-κB Family: DistinctFunctions for p65 and RelB in the Osteoclast . . . . . . . . . . . . 163Deborah Veis Novack

    Part V Roles of the TNF Family in Infectious Diseasesand Interrelationship of the TNF Family and PatternRecognition Receptor Signaling: Roles of the TNFFamily in Infectious Diseases

    18 Workshop Summary: Functions of the TNF Family inInfectious Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . 171Michael Wortzman and Tania H. Watts

    19 Role of 4-1BBL and TRAF1 in the CD8 T Cell Responseto Influenza Virus and HIV . . . . . . . . . . . . . . . . . . . . . . 177Tania H. Watts, Gloria H.Y. Lin, Chao Wang,Ann J. McPherson, Laura M. Snell, and Laurent Sabbagh

    20 Roles of Soluble and Membrane TNFand Related Ligands in Mycobacterial Infections:Effects of Selective and Non-selective TNF InhibitorsDuring Infection . . . . . . . . . . . . . . . . . . . . . . . . . . . . 187Irene Garcia, Maria L. Olleros, Valerie F.J. Quesniaux,Muazzam Jacobs, Nasiema Allie, Sergei A. Nedospasov,David E. Szymkowski, and Bernhard Ryffel

    21 Poxviral TNFRs: Properties and Role in Viral Pathogenesis . . . 203Alí Alejo, Sergio M. Pontejo, and Antonio Alcami

    22 Heme Sensitization to TNF-Mediated Programmed Cell Death . . 211Raffaella Gozzelino and Miguel P. Soares

    23 TNF-α and TNFR in Chagas Disease: From ProtectiveImmunity to Pathogenesis of Chronic Cardiomyopathy . . . . . . 221Joseli Lannes-Vieira, Isabela Resende Pereira,Nathália Ferreira Vinagre, and Lucia Elena Alvarado Arnez

    24 Lymphotoxin’s Link to Carcinogenesis:Friend or Foe? From Lymphoid Neogenesisto Hepatocellular Carcinoma and Prostate Cancer . . . . . . . . . 231Monika Julia Wolf, Gitta Maria Seleznik,and Mathias Heikenwalder

  • xvi Contents

    Part VI Roles of the TNF Family in Infectious Diseasesand Interrelationship of the TNF Family and PatternRecognition Receptor Signaling: Interrelationshipof the TNF Family and Pattern Recognition Receptor Signaling

    25 Anti-inflammatory Functions of Caspase-8 . . . . . . . . . . . . . 253Akhil Rajput, Tae-Bong Kang, Konstantin Bogdanov,Jin-Chul Kim, Tehila Ben-Moshe, Andrew Kovalenko,and David Wallach

    26 Endogenous Ligand-Induced Activation of TLR4 in Pre-metastatic Phase Is Both Downstream and Upstream ofTNF Signaling . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 261Yoshiro Maru

    Part VII Novel Aspects of Immune Regulation by the TNF Family

    27 Introductory Words About TL1A/DR3 . . . . . . . . . . . . . . . 271Stephan R. Targan

    28 Introductory Words About TWEAK/Fn14 . . . . . . . . . . . . . 275Linda C. Burkly

    29 Insights into TL1A and IBD Pathogenesis . . . . . . . . . . . . . . 279David Q. Shih, Kathrin S. Michelsen, Robert J. Barrett,Eva Biener-Ramanujan, Rivkah Gonsky, Xiaolan Zhang,and Stephan R. Targan

    30 The Role of TNFRSF25:TNFSF15 in Disease. . . and Health? . . . 289Taylor H. Schreiber, Dietlinde Wolf, and Eckhard R. Podack

    31 Identification of New Candidates as Mucosal VaccineAdjuvant in TNF Family Cytokines . . . . . . . . . . . . . . . . . 299Hiroyuki Kayamuro, Yasuo Yoshioka, Yasuhiro Abe,Kazufumi Katayama, Shuhei Arita, Tetsuya Nomura,Tomoaki Yoshikawa, Norio Itoh, Haruhiko Kamada,Shin-ichi Tsunoda, and Yasuo Tsutsumi

    32 The TWEAK/Fn14 Pathway in Tissue Remodeling:For Better or for Worse . . . . . . . . . . . . . . . . . . . . . . . . 305Linda C. Burkly and Taeko Dohi

    33 TWEAK and the Kidney: the Dual Roleof a Multifunctional Cytokine . . . . . . . . . . . . . . . . . . . . 323Ana Ortiz, M.D. Sanchez-Niño, M.C. Izquierdo,L.M. Blanco-Colio, R. Selgas, M. Ruiz-Ortega, J. Egido,and Ana B. Sanz

    34 TWEAK and TNF Regulation of Sclerostin: A NovelPathway for the Regulation of Bone Remodelling . . . . . . . . . 337David M. Findlay and Gerald J. Atkins

  • Contents xvii

    Part VIII Control of Lymphocyte Function and Repertoireby the TNF Family

    35 Workshop Summary: Control of Lymphocyte Functionand Repertoire by the TNF Superfamily . . . . . . . . . . . . . . 351Carl F. Ware and Jeffrey L. Browning

    36 The Canonical and Unconventional Ligandsof the Herpesvirus Entry Mediator . . . . . . . . . . . . . . . . . 353Timothy C. Cheung and Carl F. Ware

    37 The Lymphotoxin Pathway as a Novel Regulatorof Dendritic Cell Function . . . . . . . . . . . . . . . . . . . . . . 363Leslie Summers deLuca and Jennifer L. Gommerman

    38 Involvement of the Cytokine Receptor CD137 in MurineHematopoiesis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 375Dongsheng Jiang, Qianqiao Tang, and Herbert Schwarz

    39 LTBR-Pathway in Sjogren’s Syndrome: CXCL13 Levelsand B-cell-Enriched Ectopic Lymphoid Aggregatesin NOD Mouse Lacrimal Glands Are Dependenton LTBR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 383Roy A. Fava, Jeffrey L. Browning, Margaret Gatumu,Kathrine Skarstein, and Anne-Isine Bolstad

    40 MEK Kinase 1: Kinase Domain Deficiency in MiceReveals a Role in Orchestrating the Thymus-DependentImmunity and TNFR Family Signaling . . . . . . . . . . . . . . . 391Ewen Gallagher

    Part IX Advances in Applying Our Knowledge to Therapy:Mechanisms of Pathological and Therapeutic Effectsof the TNF Family

    41 Introduction to the Session “Mechanisms of Pathologicaland Therapeutic Effects of the TNF Family” . . . . . . . . . . . . 401Claude Libert

    42 Mechanisms Regulating TNF-Driven Gut and JointInflammation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 403Dirk Elewaut, Peggy Jacques, Lode Melis, and Koen Venken

    43 Lessons from Anti-TNF Biologics: Infliximab Failurein a TRAPS Family with the T50M Mutationin TNFRSF1A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 409Belinda Nedjai, Niamh Quillinan, Robert J. Coughlan,Leigh Church, Michael F. McDermott, Graham A. Hitman,and Mark D. Turner

  • xviii Contents

    44 Modalities of Experimental TNF Blockade In Vivo:Mouse Models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 421A.A. Kruglov, A.V. Tumanov, S.I. Grivennikov,Yu.V. Shebzukhov, A.A. Kuchmiy, G.A. Efimov,M.S. Drutskaya, J. Scheller, D.V. Kuprash,and Sergei A. Nedospasov

    45 Tumor Necrosis Factor-α Signaling via TNFR1/p55Is Deleterious Whereas TNFR2/p75 SignalingIs Protective in Adult Infarct Myocardium . . . . . . . . . . . . . 433Raj Kishore, Tengiz Tkebuchava, Sharath P. Sasi,Marcy Silver, Hu-Ya Gilbert, Young-Sup Yoon, Hee-YoungPark, Tina Thorne, Douglas W. Losordo,and David A. Goukassian

    46 TNF-α Regulation of CD38 Expression in Human AirwaySmooth Muscle: Role of MAP Kinases and NF-κB . . . . . . . . . 449Joseph A. Jude, Reynold A. Panettieri, Timothy F. Walseth,and Mathur S. Kannan

    47 Functional Consequences of Disease-Associated Mutationsin TNFR1 Elucidated by Transcriptome Analysis . . . . . . . . . 461Susana L. Rebelo, Paul M. Radford, Susan E. Bainbridge,Ian Todd, and Patrick J. Tighe

    48 Tumor Necrosis Factor-α and Kidney Function:Experimental Findings in Mice . . . . . . . . . . . . . . . . . . . 471Dewan S.A. Majid

    49 Strategies to Inhibit the Toxicity of Systemic TNF Treatment . . . 481Filip Van Hauwermeiren, Leen Puimège, Sofie Vandevyver,Tom Van Bogaert, Ineke Vanlaere, Liesbeth Huys,Lien Dejager, and Claude Libert

    Part X Advances in Applying our Knowledge to Therapy:Rational Design of New Means for TherapeuticModulation of Function of the TNF Family

    50 Workshop Summary: Introduction to Rational Designof New Means for Therapeutic Modulation of Functionof the TNF Family . . . . . . . . . . . . . . . . . . . . . . . . . . . 487Klaus Pfizenmaier and David E. Szymkowski

    51 Anti-inflammatory Effects of a Novel TNFR1-SelectiveAntagonistic TNF Mutant on Established MurineCollagen-Induced Arthritis . . . . . . . . . . . . . . . . . . . . . . 493Yasuhiro Abe, Tetsuya Nomura, Yasuo Yoshioka,Haruhiko Kamada, Shin-ichi Tsunoda, and Yasuo Tsutsumi

  • Contents xix

    52 A Proliferation-Inducing Ligand (APRIL):The Development of Antagonistic Agentsas Potential Therapeutics and Deciphering the Roleof Heparan Sulphate Proteoglycans (HSPGs) in APRILSignalling . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 501Fiona Kimberley, Marco Guadagnoli, Hans van Eenennaam,and Jan Paul Medema

    53 Genetic Engineering of Death Ligands for Improvementof Therapeutic Activity . . . . . . . . . . . . . . . . . . . . . . . . 507Jeannette Gerspach, Britta Schneider, Nicole Müller,Tina Otz, Harald Wajant, and Klaus Pfizenmaier

    54 Computational Design of TNF Ligand-BasedProtein Therapeutics . . . . . . . . . . . . . . . . . . . . . . . . . 521Almer M. van der Sloot and Wim J. Quax

    Part XI Roles of the TNF Family in Neuronal Development,Function, and Pathology

    55 Workshop Summary: Roles of the TNF Family inNeuronal Development, Function and Pathology . . . . . . . . . . 537Malú G. Tansey and Tony Wyss-Coray

    56 TNF: A Key Neuroinflammatory Mediatorof Neurotoxicity and Neurodegeneration in Modelsof Parkinson’s Disease . . . . . . . . . . . . . . . . . . . . . . . . 539Melissa K. McCoy, Kelly A. Ruhn, Armin Blesch,and Malú G. Tansey

    57 The Contribution of TNFα to Synaptic Plasticityand Nervous System Function . . . . . . . . . . . . . . . . . . . . 541David Stellwagen

    58 Intracellular and Intercellular Cross Talk Between NGFand TNF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 559Yoshinori Takei and Ronald Laskey

    59 TNFR2 – Target for Therapeutics AgainstNeurodegenerative Diseases? . . . . . . . . . . . . . . . . . . . . . 567Ingrid M. Nijholt, Ivica Granic, Paul G.M. Luiten,and Ulrich L.M. Eisel

    60 A Role for Neuronal NF-κB in SuppressingNeuroinflammation and Promoting Neuroprotectionin the CNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 575Mary Emmanouil, Era Taoufik, Vivian Tseveleki,Sotiris-Spyros Vamvakas, and Lesley Probert

  • xx Contents

    Part XII Cell Death Mechanisms Controlled by the TNF Family

    61 Workshop Summary: Cell Death Mechanisms Controlledby the TNF Family . . . . . . . . . . . . . . . . . . . . . . . . . . 585John E. Eriksson and Peter Vandenabeele

    62 A RNA Interference Screen Identifies RIP3 as an EssentialInducer of TNF-Induced Programmed Necrosis . . . . . . . . . . 589YoungSik Cho, Sreerupa Challa, and Francis Ka-Ming Chan

    63 The Extracellular Matrix Protein CCN1 Dictates TNFαand FasL Cytotoxicity In Vivo . . . . . . . . . . . . . . . . . . . . 595Chih-Chiun Chen, Vladislava Juric, and Lester F. Lau

    64 Compartmentalization of TNF-Receptor 1 Signaling:TNF-R1-Associated Caspase-8 Mediates Activationof Acid Sphingomyelinase in Late Endosomes . . . . . . . . . . . 605Uwe Bertsch, Bärbel Edelmann, Vladimir Tchikov,Supandi Winoto-Morbach, and Stefan Schütze

    65 TNF/TNF Receptor 1-Mediated Apoptosis in Hepatocytes . . . . 617Hyun-Ae Eum and Timothy R. Billiar

    66 Regulation of Cell Death by c-FLIP Phosphorylation . . . . . . . 625Tomoko Asaoka, Aura Kaunisto, and John E. Eriksson

    Appendix I:Contributors to Abstracts of Talks and Posters at the 12th

    TNF Conference . . . . . . . . . . . . . . . . . . . . . . . . . . . . 631

    Appendix II:Abstracts of Talks and Posters Presented at the 12th TNFConference . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 643

    Subject Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 829

    /ColorImageDict > /JPEG2000ColorACSImageDict > /JPEG2000ColorImageDict > /AntiAliasGrayImages false /CropGrayImages true /GrayImageMinResolution 290 /GrayImageMinResolutionPolicy /Warning /DownsampleGrayImages true /GrayImageDownsampleType /Bicubic /GrayImageResolution 600 /GrayImageDepth -1 /GrayImageMinDownsampleDepth 2 /GrayImageDownsampleThreshold 2.03333 /EncodeGrayImages true /GrayImageFilter /DCTEncode /AutoFilterGrayImages true /GrayImageAutoFilterStrategy /JPEG /GrayACSImageDict > /GrayImageDict > /JPEG2000GrayACSImageDict > /JPEG2000GrayImageDict > /AntiAliasMonoImages false /CropMonoImages true /MonoImageMinResolution 800 /MonoImageMinResolutionPolicy /Warning /DownsampleMonoImages true /MonoImageDownsampleType /Bicubic /MonoImageResolution 2400 /MonoImageDepth -1 /MonoImageDownsampleThreshold 1.50000 /EncodeMonoImages true /MonoImageFilter /CCITTFaxEncode /MonoImageDict > /AllowPSXObjects false /CheckCompliance [ /None ] /PDFX1aCheck false /PDFX3Check false /PDFXCompliantPDFOnly false /PDFXNoTrimBoxError true /PDFXTrimBoxToMediaBoxOffset [ 0.00000 0.00000 0.00000 0.00000 ] /PDFXSetBleedBoxToMediaBox true /PDFXBleedBoxToTrimBoxOffset [ 0.00000 0.00000 0.00000 0.00000 ] /PDFXOutputIntentProfile (None) /PDFXOutputConditionIdentifier () /PDFXOutputCondition () /PDFXRegistryName () /PDFXTrapped /False

    /CreateJDFFile false /Description > /Namespace [ (Adobe) (Common) (1.0) ] /OtherNamespaces [ > /FormElements false /GenerateStructure true /IncludeBookmarks false /IncludeHyperlinks false /IncludeInteractive false /IncludeLayers false /IncludeProfiles true /MultimediaHandling /UseObjectSettings /Namespace [ (Adobe) (CreativeSuite) (2.0) ] /PDFXOutputIntentProfileSelector /NA /PreserveEditing true /UntaggedCMYKHandling /LeaveUntagged /UntaggedRGBHandling /LeaveUntagged /UseDocumentBleed false >> ]>> setdistillerparams> setpagedevice